Pyrotinib combined with trastuzumab and chemotherapy in the treatment of HER2-positive metastatic breast cancer after the progression of trastuzumab therapy
{{output}}
Introduction: Retrospective studies have shown that the continuation use of trastuzumab in HER2 positive metastatic breast cancer patients who progressed during treatment with trastuzumab still may have clinical benefits. However... ...
